Lightbridge (LTBR) had the highest return between January 16, 2018 and January 22, 2018 by a small-cap US stock, returning 50.6%.
| ASSET | DATE | % RETURN |
|---|---|---|
Lightbridge (LTBR) | 1/16/2018 - 1/22/2018 | 50.65% |
Gyre Therapeutics (GYRE) | 1/16/2018 - 1/22/2018 | 40.37% |
InnovAge (INNV) | 1/16/2018 - 1/22/2018 | 38.66% |
Nutex Health (NUTX) | 1/16/2018 - 1/22/2018 | 37.5% |
Ichor (ICHR) | 1/16/2018 - 1/22/2018 | 36.74% |
Iovance Biotherapeutics (IOVA) | 1/16/2018 - 1/22/2018 | 30.94% |
Eastman Kodak (KODK) | 1/16/2018 - 1/22/2018 | 30.51% |
Novavax (NVAX) | 1/16/2018 - 1/22/2018 | 27.38% |
Kalvista Pharmaceuticals (KALV) | 1/16/2018 - 1/22/2018 | 21.28% |
Collegium Pharmaceutical (COLL) | 1/16/2018 - 1/22/2018 | 20.93% |
Perpetua Resources (PPTA) | 1/16/2018 - 1/22/2018 | 20.01% |
Sanara Medtech (SMTI) | 1/16/2018 - 1/22/2018 | 19.6% |
Aurora Cannabis (ACB) | 1/16/2018 - 1/22/2018 | 18.88% |
Newegg Commerce (NEGG) | 1/16/2018 - 1/22/2018 | 17.82% |
Know Labs (KNW) | 1/16/2018 - 1/22/2018 | 17.41% |
Syndax Pharmaceuticals (SNDX) | 1/16/2018 - 1/22/2018 | 16.72% |
Spyre Therapeutics (SYRE) | 1/16/2018 - 1/22/2018 | 16.54% |
Ramaco Resources (METC) | 1/16/2018 - 1/22/2018 | 15.13% |
Community Health Systems (CYH) | 1/16/2018 - 1/22/2018 | 14.56% |
Galiano Gold (GAU) | 1/16/2018 - 1/22/2018 | 14.46% |
BlueLinx (BXC) | 1/16/2018 - 1/22/2018 | 13.32% |
UroGen Pharma (URGN) | 1/16/2018 - 1/22/2018 | 12.48% |
Zevra Therapeutics (ZVRA) | 1/16/2018 - 1/22/2018 | 11.88% |
Cimpress (CMPR) | 1/16/2018 - 1/22/2018 | 11.51% |
Insteel Industries (IIIN) | 1/16/2018 - 1/22/2018 | 11.38% |
Small-cap stocks are treated as having a market cap between $300M and $2B.
